RegeneRx Biopharmaceuticals, Inc. President and CEO to Present at Roth Capital Partners 23rd Annual OC Growth Stock Conference

ROCKVILLE, Md.--(BUSINESS WIRE)--RegeneRx Biopharmaceuticals, Inc. (OTC Bulletin Board: RGRX) (“the Company” or “RegeneRx”) announced today that the Company will be presenting at the Roth Capital Partners 23rd Annual OC Growth Stock Conference being held at the Ritz Carlton in Dana Point, Calif. from March 14 through 16. J.J. Finkelstein, RegeneRx’s president and chief executive officer, will deliver the Company’s corporate presentation on Wednesday, March 16 at 8:30 a.m. Pacific time.

MORE ON THIS TOPIC